What it isHigh-potency lipophilic mu agonist; severe pain, anesthesia and transdermal chronic pain.
Why this oneNo active metabolites, so it is the opioid of choice in renal failure, and its lipophilicity allows patch and mucosal delivery.
What limits itThe patch takes 12 to 24 hours to work and is only for opioid-tolerant patients; heat raises absorption. Potency makes dosing errors lethal.
BOXED WARNING Risk of fatal respiratory depression, medication errors, and abuse; contraindicated in opioid non-tolerant patients and in acute/postoperative pain; fatal CYP3A4 interactions; do not convert or substitute mcg-per-mcg with other fentanyl products; TIRF REMS.
FDA dosing
Population
Start
Target
Max
Breakthrough cancer pain (opioid-tolerant)
adult
100 mcg SL PRN
individually titrated
2 doses per episode; ≤4 episodes/day
Titration Titrate to an effective dose over successive breakthrough episodes.
Renal Administer with caution in renal dysfunction.
Hepatic Administer with caution in hepatic dysfunction.
No more than 2 doses per breakthrough episode; wait ≥2 hours before treating another episode; limit to ≤4 episodes/day.
Instructions
Place on the floor of the mouth directly under the tongue and allow to dissolve completely.
Patients must require and use around-the-clock opioids.
Do not convert mcg-per-mcg from other fentanyl products; start all patients at 100 mcg.
Do not substitute for any other fentanyl product.
Contraindications
Opioid non-tolerant patients
Acute or postoperative pain, including headache/migraine, dental pain, or ER use
Cautions
MAOIs due to risk of serotonin syndrome
Respiratory and CNS depression (can be fatal even at recommended doses)
Do not convert mcg-per-mcg from other fentanyl products
Contains a dose of fentanyl fatal to a child — proper storage/disposal
Increased depressant effects with other CNS depressants and CYP3A4 inhibitors
Caution in COPD/conditions predisposing to hypoventilation and CO2 retention
Abuse potential (Schedule II)
Adverse reactions
Nausea
Somnolence
Headache
Constipation
Pregnancy Category C; chronic use associated with neonatal abstinence syndrome; use only if benefit justifies risk.
Lactation Fentanyl is excreted in human milk; do not use in nursing women (risk of sedation/respiratory depression).